ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 882,570 | $117,072,917 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 875,490 | $119,075,397 | 0.09% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 11, 2025 |
| Sept. 30, 2025 | 810,390 | $108,543,634 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 762,820 | $95,573,718 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 762,220 | $78,257,128 | 0.06% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 761,900 | $69,134,806 | 0.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.